142 related articles for article (PubMed ID: 18751353)
1. Epidemiology and costs of chronic kidney disease in North Carolina.
Vupputuri S
N C Med J; 2008; 69(3):205-7. PubMed ID: 18751353
[No Abstract] [Full Text] [Related]
2. Editorial comment.
El Nahas M
Nephron Clin Pract; 2009; 113(4):c293. PubMed ID: 19950440
[No Abstract] [Full Text] [Related]
3. Community Care of North Carolina and the medical home approach to chronic kidney disease.
DuBard CA; Cockerham J
N C Med J; 2008; 69(3):229-32. PubMed ID: 18751361
[No Abstract] [Full Text] [Related]
4. The drug add-on component--have all provider types seen budget neutrality?
Mentz K
Nephrol News Issues; 2005 Sep; 19(10):42-4. PubMed ID: 16187646
[No Abstract] [Full Text] [Related]
5. Policy forum: chronic kidney disease in North Carolina.
Ricketts TC; Hastings J
N C Med J; 2008; 69(3):196. PubMed ID: 18751351
[No Abstract] [Full Text] [Related]
6. Chronic kidney disease in North Carolina.
Alexander-Bratcher K; Plescia M; Skipper L; Silberman P; Holmes M
N C Med J; 2008; 69(3):197-204. PubMed ID: 18751352
[No Abstract] [Full Text] [Related]
7. Selected data on chronic kidney disease in North Carolina.
Buescher PA
N C Med J; 2008; 69(3):243-6. PubMed ID: 18751365
[No Abstract] [Full Text] [Related]
8. Costs and financing of kidney transplantation in the United States.
Mendez R; Aswad S; Dessouki A; Cicciarelli J; Mendez RG
Transplant Proc; 1992 Oct; 24(5):2127-8. PubMed ID: 1413009
[No Abstract] [Full Text] [Related]
9. Regarding: "Management of glomerular proteinuria: a commentary".
Brenner BM
J Am Soc Nephrol; 2004 May; 15(5):1354-5; discussion 1356-7. PubMed ID: 15100378
[No Abstract] [Full Text] [Related]
10. Drugs take the spotlight in steering clinical, economic direction for ESRD.
Neumann ME
Nephrol News Issues; 2004 Jun; 18(7):50-1. PubMed ID: 15232997
[No Abstract] [Full Text] [Related]
11. Renin-angiotensin system inhibitors in proteinuric chronic kidney disease.
Hirsch S
Compr Ther; 2009; 35(2):91-5. PubMed ID: 19618757
[TBL] [Abstract][Full Text] [Related]
12. Genetics and kidney disease. Duke Med Scholars Program.
Krentz JF
N C Med J; 2008; 69(3):247. PubMed ID: 18751366
[No Abstract] [Full Text] [Related]
13. Public health initiatives to prevent and detect chronic kidney disease in North Carolina.
Pullen-Smith B; Plescia M
N C Med J; 2008; 69(3):224-6. PubMed ID: 18751358
[No Abstract] [Full Text] [Related]
14. Chasing the (MCP) codes.
Amerling R
Nephrol News Issues; 2004 May; 18(6):34. PubMed ID: 15160417
[No Abstract] [Full Text] [Related]
15. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.
Onuigbo MA
Hemodial Int; 2009 Oct; 13 Suppl 1():S24-9. PubMed ID: 19775421
[TBL] [Abstract][Full Text] [Related]
16. The impact of cyclosporine costs on kidney transplants.
Siegal BR
Healthspan; 1985; 2(8):15-9. PubMed ID: 10300376
[No Abstract] [Full Text] [Related]
17. Pediatric chronic kidney disease in North Carolina.
Ferris M; Patel UD; Massengill S; Gipson D; Conley W; Layton JB; Nagaraj S; Primack W
N C Med J; 2008; 69(3):208-14. PubMed ID: 18751354
[No Abstract] [Full Text] [Related]
18. Risk factors for the development and progression of renal diseases in disadvantaged populations: role of the renin-angiotensin system blockade.
Maione A; Strippoli GF
Ethn Dis; 2009; 19(1 Suppl 1):S1-86-9. PubMed ID: 19484883
[TBL] [Abstract][Full Text] [Related]
19. The National Kidney Foundation of North Carolina.
Skipper L
N C Med J; 2008; 69(3):227. PubMed ID: 18751359
[No Abstract] [Full Text] [Related]
20. Vitamin D update. Medicare carrier abandons plan to "ration" i.v. vitamin D in North Carolina, but not South Carolina.
Nephrol News Issues; 2002 Apr; 16(5):55, 58. PubMed ID: 11962152
[No Abstract] [Full Text] [Related]
[Next] [New Search]
